Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer. (2023)
Attributed to:
Evaluating new healthcare technologies in cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/prca.202200114
PubMed Identifier: 37147936
Publication URI: http://europepmc.org/abstract/MED/37147936
Type: Journal Article/Review
Volume: 17
Parent Publication: Proteomics. Clinical applications
Issue: 4
ISSN: 1862-8346